BSGM vs. RMTI, FONR, VANI, HYPR, CUTR, ECOR, POCI, IRIX, MOVE, and PXDT
Should you be buying BioSig Technologies stock or one of its competitors? The main competitors of BioSig Technologies include Rockwell Medical (RMTI), FONAR (FONR), Vivani Medical (VANI), Hyperfine (HYPR), Cutera (CUTR), electroCore (ECOR), Precision Optics (POCI), IRIDEX (IRIX), Movano (MOVE), and Pixie Dust Technologies (PXDT).
BioSig Technologies (NASDAQ:BSGM) and Rockwell Medical (NASDAQ:RMTI) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, earnings, community ranking, dividends, profitability, valuation, risk, media sentiment and analyst recommendations.
BioSig Technologies has a net margin of 0.00% compared to Rockwell Medical's net margin of -9.72%. Rockwell Medical's return on equity of -28.29% beat BioSig Technologies' return on equity.
Rockwell Medical has a consensus target price of $7.00, indicating a potential upside of 270.37%. Given Rockwell Medical's higher probable upside, analysts plainly believe Rockwell Medical is more favorable than BioSig Technologies.
BioSig Technologies has a beta of 0.84, indicating that its stock price is 16% less volatile than the S&P 500. Comparatively, Rockwell Medical has a beta of 1.29, indicating that its stock price is 29% more volatile than the S&P 500.
7.2% of BioSig Technologies shares are owned by institutional investors. Comparatively, 23.3% of Rockwell Medical shares are owned by institutional investors. 9.3% of BioSig Technologies shares are owned by insiders. Comparatively, 1.9% of Rockwell Medical shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
Rockwell Medical received 200 more outperform votes than BioSig Technologies when rated by MarketBeat users. However, 70.34% of users gave BioSig Technologies an outperform vote while only 57.31% of users gave Rockwell Medical an outperform vote.
In the previous week, Rockwell Medical had 2 more articles in the media than BioSig Technologies. MarketBeat recorded 2 mentions for Rockwell Medical and 0 mentions for BioSig Technologies. Rockwell Medical's average media sentiment score of 1.36 beat BioSig Technologies' score of 0.00 indicating that Rockwell Medical is being referred to more favorably in the news media.
Rockwell Medical has higher revenue and earnings than BioSig Technologies.
Summary
Rockwell Medical beats BioSig Technologies on 11 of the 15 factors compared between the two stocks.
Get BioSig Technologies News Delivered to You Automatically
Sign up to receive the latest news and ratings for BSGM and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding BSGM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
BioSig Technologies Competitors List
Related Companies and Tools
